Compare BLD & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLD | RGEN |
|---|---|---|
| Founded | 2015 | 1981 |
| Country | United States | United States |
| Employees | 14707 | N/A |
| Industry | Engineering & Construction | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0B | 6.6B |
| IPO Year | 2015 | 1995 |
| Metric | BLD | RGEN |
|---|---|---|
| Price | $424.72 | $132.85 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 12 |
| Target Price | ★ $444.33 | $167.67 |
| AVG Volume (30 Days) | 735.6K | ★ 888.4K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 286.96 |
| EPS | ★ 3.73 | 0.15 |
| Revenue | ★ $2,384,249,000.00 | $141,236,000.00 |
| Revenue This Year | $13.36 | $14.30 |
| Revenue Next Year | $4.27 | $14.52 |
| P/E Ratio | ★ $113.75 | $886.67 |
| Revenue Growth | 25.07 | ★ 35.10 |
| 52 Week Low | $312.23 | $100.99 |
| 52 Week High | $559.47 | $175.77 |
| Indicator | BLD | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 57.82 | 61.61 |
| Support Level | $416.08 | $130.40 |
| Resistance Level | $442.00 | $172.45 |
| Average True Range (ATR) | 10.41 | 5.37 |
| MACD | 1.93 | 0.90 |
| Stochastic Oscillator | 98.21 | 76.17 |
TopBuild Corp is an installer and distributor of insulation products. Its operating segments are: Installation Services and Specialty Distribution. The Installation Services segment, which generates maximum revenue, installs insulation, commercial roofing, and other building products like glass and windows, rain gutters, doors, etc, mainly in the residential new construction market. The Specialty Distribution segment distributes building and mechanical insulation, insulation accessories, and other building product materials for the residential, commercial, and industrial markets. In addition to insulation and accessories, it distributes rain gutters, closet shelving, roofing materials, and other items. Geographically, the firm mainly operates in the U.S. and, to a lesser extent, in Canada.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.